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The use of materials to impose tissue-like architecture at cell resolution will be important if engineered 
functional replacements for damaged cardiovascular, pulmonary, renal or digestive tissues are to be 
authentically engineered. Here, we demonstrate a coordinated system for the fabrication and subsequent 
culture of tubular tissues composed of multiple layers, cell-types and materials with physiological 
dimensions and defined architectures at cell resolution. We developed an automated tube fabricator (ATF) 
that rolls 2D-matrices into 3D-tubular constructs directly from cells, hydrogels and scaffold biomaterials. 
Coordinated use of surface modification strategies allows 2D cell sheets and cell/biomaterial composites 
(i.e. hydrogels or electrospun scaffolds) to be fabricated which may be transferred into a perfusion 
bioreactor in a rapid and standardized procedure. To exemplify our strategy we fabricated structures 
resembling human mammary artery and gut; these can be imaged in situ and real-time electrical resistance 
measurements performed of the vessel walls, allowing non-invasive assessment of viability and 
functionality. Our system allows patterning at cellular resolution with variable tissue thickness, length, 
luminal diameter, and constituent biomaterial. This inherent flexibility will allow the recapitulation of the 
complex hierarchical biological architectures and generate functionality found natively in vivo. 
 
Introduction 
Various obstacles hinder tissue engineered vessel development including recreating the substantial 
mechanical strength and biological activity in situ grafts require on transplant. Furthermore these conduits 
need to be immunologically inert and non-thrombotic for successful long-term post-transplantation 
patency and for clinical adoption (Kakisis et al., 2005, Baguneid et al., 2006). Fundamental construct 
fabrication considerations include; dimension standardization, and for biologically active architectures, 
factors such as seeding, positioning and patterning of cells within different layers throughout tissues. To 
address these, various methodologies have been applied including synthetic scaffolds, biocompatible 
natural scaffolds, cell sheet technologies, automated (McAllister et al. 2006) or self-assembly of vessels 
(Baguneid et al., 2006, Kakisis et al., 2005, Peck et al., 2012, Nerem and Seliktar, 2001, Kubo et al., 2007, 
Williams et al., 2009). Some models have shown good patency in animal models (Niklason et al., 1999, Kim 
et al., 2008, Shum-Tim et al., 1999, Wang et al., 2013), with few progressing to human trials (Shin'oka et al., 
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2005, Shin'oka et al., 2001, McAllister et al., 2009). This limited success highlights the necessity to improve 
graft fabrication processes and facilitate the use of multi-phase materials to create tissues (Peck et al., 
2012, Baguneid et al., 2006). Multilayer tubes have been engineered using various approaches including 
manually rolling cell sheets around a mandrel (L'Heureux et al., 2006, L'Heureux et al., 1998, Seliktar et al., 
2000), tubular constructs requiring external structural supports to prevent tube disassembly (Papenburg et 
al., 2009), cell sheet rolling technologies (Kubo et al., 2007), or self-rolling stretched synthetic materials 
(Yuan et al., 2012). Manual rolling with or without additional external support is technically complex and 
requires lengthy tissue maturation, whilst the presence of stabilizing materials prevents usefulness in 
downstream applications. Self-rolling materials are generally not biocompatible for long-term viability, and 
the mechanical forces placed on cells may directly affect cell behaviour (Engler et al., 2006). The application 
of cell sheet patterning technologies allows precise positioning of cells within a 2D layer (Williams et al., 
2009), however the only previous example of an automated tube fabrication strategy required sheets to be 
suspended in solution, preventing controllable sheet orientation (Kubo et al., 2007). Here, we focused on 
devising a methodology to fabricate example tissues with these attributes. 
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Material and Methods 
Materials 
Materials were purchased from Sigma-Aldrich (Dorset, UK) unless stated otherwise. NIH-3t3 mouse 
embryonic fibroblasts (3T3s), human umbilical vein endothelial cells (HUVECs), BJ6 fibroblast cells and 
CACO-2 cells were obtained from the LGC Standards (Middlesex, UK). Primary human airway smooth 
muscle cells (SMCs) were isolated from bronchial biopsies at the Glenfield Hospital (Leicester, UK) as 
described previously.(Kaur et al., 2006) The research was approved by the Leicestershire Ethics Committee, 
and patients gave their written informed consent. HUVEC media was supplied by Promocell (Heidelberg, 
Germany). DMEM media, rat tail collagen I, mouse monoclonal anti-E-cadherin, and rhodamine-conjugated 
secondary antibody were obtained from Invitrogen Life Technologies (Paisley, UK). Lentiviral labelling of cell 
lines was performed as described previously (Dixon et al. 2011, Paik et al. 2012). Cells were infected with 
enhanced green fluorescent protein (GFP)- or monomeric red fluorescent protein (mRFP)-labelled lentivirus 
at confluence and selected with puromycin for 7 days which produced >95% labelled cells confirmed by 
flow cytometry.  
 
Cell Maintenance 
Cells were cultured in isolation at 37°C in a 5% CO2 incubator. 3T3, SMC, CACO-2, and BJ6 cells were 
maintained in DMEM media containing 10% (v/v) FCS and 1% penicillin/streptomycin. HUVEC cells were 
maintained in endothelial cell growth media supplemented with 0.02% (v/v) FCS, 0.004% (v/v) endothelial 
cell growth supplement, 0.1ng/ml epidermal growth factor, 1ng/ml basic fibroblast growth factor, 90 µg/ml 
heparin, 4 µg/ml hydrocortisone, and 1% penicillin/streptomycin. 
  
Preparation of Collagen cell sheets  
Collagen sheets (2mg/ml; 25x15mm2) loaded with cells (3t3s, 2x106/sheet) were crosslinked within filter 
paper frames for 1hr at 37°C and were cultured until confluency (3 days). Filter paper frames were used to 
transfer sheets to the ATF and the frame excised before fabrication. 
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Preparation of Thermo-responsive Surfaces and Monolayer or Micro-patterned Cell Sheets 
Non-treated tissue culture plastic was coated with 5µl/cm2 of 5% PNIPAAm (w/v) in distilled water using an 
EClA500 HP-CS gravity-fed air-brush at 20 pounds per square inch (psi) (The Airbrush Company Ltd., UK). 
For grafting these were heated to 65°C for 12 hours. 5µl/cm2 of 100% FCS was deposited on PNIPAAm-
coated dishes by air brushing coating the full surface for monolayers or through micropatterned stencils 
(Tannlin Ltd, UK) for patterning cells (Paik et al., 2012). Cells (6x106 cells) were seeded onto surfaces or 
micropatterns in media without FCS or Ca2+. For monolayers after confluency was achieved alginate-wetted 
(1.2% w/v) filter paper frames were placed onto the monolayer, the alginate crosslinked with 135mM CaCl2 
to adhere to the underlying outer portion of the monolayer and the sheet detached through reduction in 
temperature to 4°C and gentle agitation. For patterns alginate (1.2% w/v) was used to overlay the pattern 
within a filter paper frame, the alginate crosslinked and detached as above. Filter paper frames were used 
to transfer sheets to the ATF and the frame excised before fabrication. 
 
Electrospun Scaffold Fabrication 
Electrospun scaffolds was produced in a vented chemical fume hood at room temperature using 10% PET 
(w/v) (foods grade drinking bottle quality) dissolved in a 1:1 trifluoroacetic acid (TFA):di-chloromethane 
(DCM) (Fisher Chemicals, Loughborough, UK). Polymer solution was loaded into a syringe attached to a 
blunt 23-gauge (G) needle (BD Falcon™, Oxford, UK) and placed in a pump-driver (Harvard Apparatus Ltd., 
Kent, UK) extruding at 0.5ml/hr. A 15kV voltage was applied and nanofibres were collected on a steel 
collector plate positioned 15cm from the needle tip. Scaffolds were attached to Perspex frames and 
sterilized by UV-irradiation for 30min. For seeding scaffolds were soaked in media prior to CACO-2 cell 
seeding (1x106 Caco-2 cells/25x15mm2 scaffold). Perspex frames were used to transfer sheets to the ATF 
and the scaffold excised before fabrication. 
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Fabricating Vessels 
 The ATF (developed and manufactured by the Medical Engineering Unit, University of Nottingham) consists 
of stepper-motor driven modules, a mandrel rotation module driven by two inversely rotating facing 
stepper-motors and a sample delivery module, and a stage to deliver the material to the mandrel rotation 
module. Distance between the stage and mandrel is manually (or automatically) controlled to bring the 
sample in contact with mandrel. Using the programmable system the automated fabrication was initiated 
and the mandrel rotation module rotated (0.1-1 rotations/second) to draw up the sample. This action 
occurs simultaneously as the stage advancing; the stage covering the same distance as the circumference of 
the mandrel at the same rate as mandrel rotation. The fabricated tube (directly integrated into the tube 
holder mounts) was transferred into the jig. For Fibrin hydrogel bonding; 20µl/cm2 of 16mg/ml Human 
Fibrinogen was incubated with cell sheets, hydrogels or biomaterial for 5mins at 25˚C. 20µl/cm2 of 200U/ml 
Human Thrombin was either airbrushed onto the tube mounts or incubated with the previously fabricated 
layer for 5mins at 25˚C. Bonding of the tube mounts and the first layer was allowed to take place for 5mins 
before fabrication. 
 
Transepithelial Electrical Resistance (TEER) Measurements with Calcium Depletion 
CACO-2 populated tubular constructs connected to the bioreactor system had electrodes inserted within 
the tube lumen and the perfusion chamber that were connected to an EVOM2 volt-ohm-meter (World 
Precision Instruments, Hitchin, UK). Background conductance was removed by subtracting acellular scaffold 
readings. Media was replaced with CRB (Dixon et al. 2014) for 5min at room temperature which was then 
replaced by growth media (which contains 2mM CaCl2). TEER readings were taken periodically over a 24hr 
time period and are expressed as a percentage of the initial TEER reading (Ω/Ω0)/cm
2. 
Dextran Permeability 
CACO-2 populated tubular constructs were incubated in serum-free media at 37°C for 1hr. A solution 
containing both 4kDa FITC-tagged dextran and 70kDa-Rhodamine-tagged dextran (1mg/ml) was added to 
the tube lumen. Media in the perfusion chamber was replaced with CRB for 5min at room temperature 
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before replacing with normal media.  Samples were collected from the perfusion chamber over a 2hr 
period post-CRB application and fluorescence quantified on a plate reader (excitation 520nm/emission 
590nm) (Tecan Infinite M200, Reading UK).  
 
Immunocytochemistry 
Samples were calcium depleted for 5min before immediate fixation and permeabilization using 100% 
methanol at -20oC. Non-specific antibody binding was reduced by incubation in 3% (w/v) bovine serum 
albumin solution. Samples were incubated with anti-E-cadherin antibody overnight at 4oC, with protein 
expression visualised with species-appropriate secondary antibody.  
 
Construct Visualization  
Composite tubular formations were visualized using a Nikon Eclipse TS100 Microscope (Nikon Instruments, 
Surrey, UK). Entire surface micropatterns images were captured by Nikon SMZ 1500 microscope with a 
SPOT insight camera. To view 3D tubes, and E-cadherin staining a TCS LSI super zoom confocal microscope 
was used (Leica Microsystems, Milton Keynes, UK). 
 
Data and Statistical Analysis 
Data are presented for cells cultured on at least three separate occasions and are expressed as mean±SEM. 
Data were analysed (GraphPad Prism, San Diego CA) using unpaired T-test. 
 
 
 
 
 
8 
 
Results 
Development of the ATF 
To produce viable, multi-layered, 3D-tubular architectures from 2D-cellular sheets, we developed the ATF 
to perform pre-determined automated tube rolling protocols (Figure 1A & B). We have developed this 
technology to be unrestricted as to the material used for fabrication and to allow patterned materials to be 
employed in an orientated fashion. The device is integrated into a sterile culture hood and consists of 3 
stepper-motor driven modules: i) a ‘mandrel rotation’ module driven by two inversely rotating facing 
stepper-motors, ii) a ‘sample delivery’ module; a stage to deliver the material to the mandrel rotation 
module, and iii) a ‘transfer module’; a system to transfer the construct to a compatible perfusion 
bioreactor. The fabrication process is complete within minutes and can rapidly reset to build multi-layer, 
multi-phase or multi-material architectures. The distance between the stage and mandrel is automatically 
or manually controlled to bring the 2D-material in contact with mandrel (Figure 1A, No 10). Fabrication is 
remotely initiated and the mandrel rotates at the same speed as the delivery stage (programmed from 0.1-
1 rotations/second) to draw up and roll the sample. If required, thrombin/fibrinogen bonding can be 
employed to integrate multiple-phases; the mandrel coated with thrombin and the cell sheet/material 
treated with fibrinogen solution (Figure 1C). Contact between the thrombin (mandrel) and the fibrinogen 
(sheet/material) creates a fibrin hydrogel which securely bonds the surfaces. During fabrication, fibrin 
forms crosslinks between adjacent layers and creates a fully adhered structure. Fabricated tubes are 
securely integrated into tube holder mounts (Figure 1A, No 4) and transferred to sterile culture jigs using 
the rotating tube transfer Y-arm (Figure 1A, No 3). This can then be installed in the complementary 
bioreactor system (Figure 3A), ensuring no further tube manipulation is required for effective construct 
perfusion. (Tube fabrication demonstrated in Video S1). If necessary the fabricated vessels can be detached 
from the bioreactor manually which is not prevented by using Fibrin within the structure. 
Fabrication of vessels with varying dimensions and phases 
Construct dimensions can be manipulated by varying different parameters: Wall thickness is determined by 
the 2D-material thickness and/or number of rotations around the mandrel (5µm->1cm). Length can be 
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adjusted by repositioning the mandrel rotation motors (Figure 1B; purple arrows) and/or varying cell-sheet 
width (<1mm-5cm). Here we demonstrated short vessels of several centimetres but clinically relevant 
lengths (15-60cm long) could be fabricated by modifying the motor distance and using further cell sheets to 
bond the junctions between several tube sections. Luminal diameter is varied using differently sized holder 
mounts (100µm-5cm). This flexibility ensures constructs possess dimensions comparable to various human 
tubular tissues. As examples, using a PET electrospun scaffold and alginate composite, we fabricated single-
phase tubular architectures with dimensions applicable to grafts from the aorta, gut, trachea, medium 
diameter arteries and urethra (Figure 1D). 
Multi-phase constructs are fabricated by sequentially rolling cellular-sheets/materials. A tri-phasic tubular 
structure consisting of a single cell monolayer and two cell-seeded collagen gels was fabricated (Figure 2A) 
as an exemplar. Initially a GFP-labelled NIH3T3 (GFP-3t3s) cell monolayer was rolled around the mandrel 
(1.05 rotations, 5µm layer thickness), followed by an mRFP- (mRFP-3t3s) and a GFP-3t3s seeded collagen 
gel (both 1.05 rotations, ~250µm layer thickness) (Figure 2A-E). Cell monolayers were created by surface 
modification of non-tissue culture-treated surfaces airbrushed with the temperature-sensitive polymer 
poly(N-isoproplacrylamide) (PNIPAAm) and foetal calf serum (FCS) prior to cell culture to confluence 
(Williams et al., 2009). PNIPAAm grafting was conducted using temperature-dependent absorption (65°C 
for 12 hours). This was chosen over other techniques such as UV- or microwave-radiation due to ease of 
processing samples. For simplicity and before temperature-sensitive detatchment, cell monolayers were 
cross-linked to an outer paper frame coated in alginate. This suspends the monolayer between the support 
allowing it to be easily transferred to the ATF for fabrication (Figure S1). A temperature reduction (4°C) 
allows the harvest of a complete cell monolayer sheet (Figure S2A) without damaging cell-deposited 
extracellular matrix (ECM)(Shimizu et al., 2001, Shimizu et al., 2006).  We analysed the complete fabricated 
tubes demonstrating layer integrity was maintained, with no significant cell migration into adjacent phases 
(Figure 2D: hydrogel to hydrogel; Figure 2E: monolayer to hydrogel) after 7 days of culture. Importantly 
however layers were integrated with cells at the phase surfaces in direct contact (Figure 2D; white arrow 
show integration, black arrows show phase interface).  
 
10 
 
Creation of patterned architectures 
To demonstrate the utility of our technology inter- and intra-layer cell patterning (with micrometre 
resolution over an extended distance) within the tubular architectures was achieved by adapting our 
previous high-resolution cell patterning technology (Figure S2A)(Paik et al., 2012). We employed 
micropatterned stencils and airbrushing to generate 50µm-wide lines of PNIPAAm interspersed with 50µm 
intervals on non-tissue culture plastic surfaces which we used to pattern GFP-3T3s (Figure 2F). We chose 
such large spacing between patterned lines to help visualisation however smaller gaps could be used to 
create orientated sheets rather than simple micropatterns. Patterns could be transferred by overlaying and 
detaching alginate-crosslinked sheets. These sheets maintained cellular patterning and were fabricated into 
vessels using the ATF (Figure 2G). In many tubular tissues luminal capacity is controlled by the surrounding 
smooth muscle cells (SMCs) which orientate uni-axially to ensure co-ordinated muscle contraction (Dobrin, 
1978). We therefore used this patterning to demonstrate effective cell alignment that can be directed into 
a helical orientation (evident in the larger airway bronchioles and small resistance arteries)(Jeffery, 2001, 
Rhodin, 1980) or herringbone alternating orientations  (found in larger elastic arteries which maintain wall 
structural integrity)(Rhodin, 1980). The herringbone motif was recapitulated using micro-patterning and 
ATF sheet fabrication; GFP-3T3 and mRFP-3T3 micropatterned cell sheets at 60° (mRFP-3T3) and 120° (GFP-
3T3) from horizontal respectively (Figure S3; example orientation). These two layers were fabricated 
sequentially to produce a 3D-tubular architecture with a herring bone motif found in native blood vessels 
(Rhodin, 1980) (Figure 2H), and previously modelled in 2D (Williams et al., 2011). Using materials such as 
aligned electrospun fibres would be useful to create orientation of cells which precisely mimic the in vivo 
situation (Morris et al. 2014).  
 
Fabrication of an arterial biomimetic 
We recapitulated a complete vascular conduit comprising of four cell layers to mimic the individual regions 
found within a blood vessel wall (Rhodin, 1980)  (Figure 2I) with dimensions comparable to an adult internal 
mammary artery (IMA) routinely used in heart bypass surgery (2.3-3.4mm external diameter, 0.6-0.75mm 
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wall thickness)(van Andel et al., 2003, Karaman et al., 2012). To ensure clear visualization of each cell-type 
post-fabrication, GFP-labelled HUVEC endothelial cells (GFP-HUVEC), mRFP-labelled smooth muscle cells 
(mRFP-SMC), and GFP-labelled BJ6 fibroblast cells (GFP-BJ6) were generated by lentiviral genetic 
modification (Dixon et al., 2011). Initially, individual 2D-sheets of GFP-HUVEC cells (3x106 cells), two aligned 
sheets of mRFP-SMC (1x106 cells), and a sheet of GFP-BJ6 cells (3x106 cells) were cultured as 2D-sheets for 2 
days before sequential cell-sheet rolling and tube imaging (Figure 2J). The two SMC layers were rolled in 
the same orientation to allow visualization of the individual cell layers.  
 
Creation of tubular tissues with Gut-like Barrier function 
Electrospun scaffolds are another biomaterial extensively used in tissue engineering that can mimic the 3D 
nano-topography of basement membranes on which epithelial cells reside in tubular architectures (Dalton 
et al., 2012, Teo and Ramakrishna, 2006, Booth et al., 2012). Exploitation of such technology has been 
mainly concentrated on regenerative purposes, with tissue engineered vascular (Shin'oka et al., 2005, 
Patterson et al., 2012, Kim et al., 2008, Wang et al., 2013) and tracheal (Jungebluth et al., 2011) grafts 
successfully transplanted into humans. To demonstrate the versatility of the ATF in fabricating various 
biomaterials, a simple epithelial tubular structure populated with the gut epithelial CACO-2 cell-line on a 
nanofibrous polyethylene terephthalate (PET) electrospun scaffold was created (Figure 3C). The 
epithelium’s primary function is to provide a physical barrier between adjacent environments whilst 
allowing a controlled para-cellular flow of nutrients and ions, and maintaining cellular polarization and 
structural integrity (Mullin et al., 2005). Inter-cellular barrier junctions consist of tight- and adheren-
junctions to control barrier integrity and porosity (Schneeberger and Lynch, 2004, Gumbiner, 1996). The 
trans-epithelial electrical resistance (TEER) was measured as an indicator of barrier function. During initial 
2D-cell sheet culture period, CACO-2 cells showed a TEER increase, with negligible increases seen after 10 
days indicating functional barrier formation. 3D-tubular, cell-populated scaffolds were fabricated on the 
ATF and transferred to the compatible bioreactor system (Figure 3A). Real-time TEER measurements within 
the bioreactor system were taken by inserting electrodes inside the lumen of the tube (Figure 3A [V2 & I2] 
& 3B), and externally to the construct in the bioreactor perfusion chamber (Figure 3B, V1 & I1). These 
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electrodes were connected to an EVOM2 machine measuring voltage (V1 & V2) and amplitude (I1 & I2) to 
quantify resistance across the tubular wall (Figure 3A). 
Relative levels of extracellular and intracellular calcium can directly affect epithelial layer barrier integrity 
(Cereijido et al., 1978, Gumbiner and Simons, 1986), a phenomenon applied to examining the modulation 
of barrier integrity in gut and kidney models (Gumbiner and Simons, 1986, Ye et al., 1999, Ivanov et al., 
2004b, Kwak et al., 2012). This short-term, reversible effect is induced through the dis-assembly of the 
inter-cellular junctional complexes (Ivanov et al., 2004a). CACO-2 populated tubes were incubated in a 
calcium reducing buffer (CRB), known to chelate calcium (Dixon et al. 2014) for 5 minutes before replacing 
with normal media (containing 2mM Ca2+) for a further 24hrs. Epithelial barrier permeability during this 
period was measured through TEER and para-cellular permeability. The reduction of extracellular calcium 
produced an instantaneous drop in TEER (67±5vs 144±8 Ω/cm2; mean ± SEM, n=3) with the re-introduction 
of calcium providing an equally robust restoration in electrical resistance that returned to initial levels after 
24hrs (Figure 3E). Inter-cellular junction integrity was visualised by immunostaining the adheren-junction 
protein E-cadherin at 5min and 24hrs post-calcium depletion. The classic “chicken-wire” E-cadherin 
distribution prior to calcium reduction was disrupted at 5min and restored after 24hrs (Figure 3D). In 
parallel, barrier integrity was monitored by small-molecule permeability. Using fluorescently-labelled 
dextran (4kDa FITC-dextran and 70kDa Rhodamine-dextran) allowed the analysis of different sized molecule 
diffusion within individual samples. Dextran was applied to the lumen of either blank electrospun scaffold 
tube, or a CACO-2 populated tube, and samples were taken from the perfusion chamber over a 2hr time 
course. Diffusion through acellular tubes was greater than cellular tubes (Figure 3F), whilst CRB treatment 
of cellular tubes significantly increased the rate of dextran diffusion over the time course. Lower weight 
dextran (4kDa) showed an increased diffusion rate compared to larger dextran molecules (70kDa) (Figure 
3G). These data indicate CACO-2 fabricated architectures possess functional barrier properties that restrict 
para-cellular diffusion in a size dependent manner.  Therefore we fabricated an intestinal tubular tissue 
that could be employed for drug screening strategies.   
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Discussion 
Here we have demonstrated an automated fabrication system to create multi-layer, multi-phasic, 
patterned tubular structures in which biomaterials, hydrogels or cells can be used as the base material. In 
conjunction with previously described patterning technology (Paik et al. 2012) and temperature-responsive 
polymers (PNIPAAM) (Williams et al., 2009) this technology allows precise positioning of cells in 3D 
architectures.  
This study has demonstrated that dimension standardization can be achieved in biologically active 
architectures and issues such as seeding, positioning and patterning of cells within different layers 
throughout tissues can be addressed directly during fabrication beyond the attempts of other studies (Peck 
et al., 2012, Baguneid et al., 2006). Manual fabrication of vessels used in previous studies (L'Heureux et al., 
2006, L'Heureux et al., 1998, Seliktar et al., 2000) is not easily achievable when multi-layer, –phasic 
patterned architectures are required which prompted the development of the ATF system. An automated 
system presents theoretical advantages over manual fabrication. However cost and system complexity 
must be offset with an improvement in vessel quality, speed of production and less need for technical 
ability needed for manual fabrication. Previous cell sheet rolling technologies (Kubo et al., 2007; McAllister 
et al 2006) have produced fabricated vessels however the technicality of manipulating delicate and 
hydrated hydrogels or cell sheets prompted us to develop a system in which 2D materials are fed into the 
fabrication mechanism yielding much more reproducible constructs and allowed patterned cellular 
structures to be fabricated (Williams et al., 2009). Furthermore by integrating the ATF system to transfer 
constructs to perfusion chambers directly the inherent variability of manual manipulation to allow 
bioreactor mounting and perfusion is removed. We demonstrated the use of fibrin to bond sheets during 
fabrication. Fibrin confers the advantage of rapid adherence between fabricated sheets but does have it 
disadvantages; Fibrin inclusion adds cost and could interfere with fusion of layers due to the biological 
activity of cells following fabrication during maturation. Furthermore the fibrin component was not 
sufficient to provide sufficient mechanical strength to create viable blood vessel mimetic constructs. 
Importantly, Fibrin is not essential to our system and its use could be emitted. Further analyses regarding 
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any thrombogenic activity of Fibrin in these constructs will also need to be tested before in vivo translation 
however this is unlikely (Kheirabadi et al. 2006). 
Even with our technology, materials that are fully bioactive and provide the substantial mechanical strength 
will need to be developed if living tissue is to be engineered as vascular grafts. However as the ATF system 
can be employed with any 2D material this methodology could be used to fabricate vessels with such 
materials (Kakisis et al., 2005, Baguneid et al., 2006).  Using the ATF system for fabrication of vasculature 
employing materials with the correct mechanical properties is now the focus of future work.  
 
Conclusion 
This novel automated platform allows accurate, standardized and repeatable fabrication of tubular 
architectures; comprised of multiple compact, stable and secure cell and/or material layers. These 
fabricated tissues are directly transferred to a compatible perfusion bioreactor without further 
manipulation. Rolling of each layer takes less than a minute and because no external material is required to 
maintain the structure except the cells with or without a biomaterial, it can be considered as an authentic 
living structure. We demonstrated our systems utility in fabricating vessels with arterial-like cell patterning 
and gut-like barrier function. This technology is easily adaptable to fabricate multiple biomaterial-types to 
engineer a variety of biologically stable tissues directed for regenerative or in vitro diagnostic protocols. 
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Figure 1. Automated tube fabricator (ATF) and fabricated vessels. A) Schematic of ATF. Sample sheets are 
delivered through an x-axis sliding stage from a computerised stepper motor (which can be positioned in 
the y-axis; purple). Tubes are rolled onto a mandrel driven by paired computerised stepper motors (green). 
Samples are attached to the stage using a vacuum line (red). After rolling, the machine may be reset to roll 
subsequent layers or the tube transferred to culture jigs (orange). B) Photograph of the ATF. Numbers 
indicate the features as described on the schematic. C) Flow diagram of tube fabrication process including 
the movements of the ATF (colour labels match the scheme and photograph). D) Examples of tubular 
constructs of different sizes and thicknesses fabricated using the ATF. Tubes were fabricated from PET 
electrospun scaffolds and alginate. These mimic the gross dimensions of Aorta/gut, Trachea, Medium 
artery and Urethra (left-right). Top image shows tube diameter bottom image shows wall thickness (wt). 
Rotation symbol indicates the number of rotations/layers used for fabrication. Examples of two internal 
mammary artery (IMA)/ coronary artery (CA) sized vessels with 1 or 3 rotations. E) Example of a vessel 
fabricated by the ATF (with IMA dimensions) within the perfusion bioreactor system. Bar is 3mm. 
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Figure 2. Multi-layer & -thickness vessel fabrication. A) Schematic of the monolayer and collagen hydrogel 
sheets employed for multi-layer and –thickness tube fabrication using fluorescently labelled NIH3t3 cells. B) 
Cross-sectional image of the multiple layers within fabricated tube. Bar is 2 mm. C) High-magnification 
images of the interface between the hydrogels (D) and the monolayer/hydrogel (E) layers within tube wall. 
Black arrows show phase interface. Bar is 2mm. D) Confocal image showing complete integration of both 
hydrogel layers and interaction of cells from both layers. E) Confocal image showing interaction of cell 
monolayer and hydrogel layer. Bar is 100µm on left panel and 20µm on right panel in D & E. Black bars 
show phase interface. F) Representative 2D cell-sheet patterning (50µm width with 50µm gaps). Patterned 
PNIPAAm-polystyrene surfaces with GFP-labelled NIH3t3s cells (Bright-field and fluorescence images). Bar is 
200µm. G) Transfer of patterned cells to alginate hydrogel sheet (Bright-field and fluorescence images). H) 
Alginate sheets patterned with GFP- and mRFP labelled NIH3t3 cells were excised to produce angled 
(horizontal +/- 30˚; 60 and 120˚) 2D cell-sheets and rolled on the AFM to produce a tubular herringbone 
pattern; green-only, red-only and merged channels are shown. Bar is 1.5mm. I) Schematic of a muscular 
artery structure (0.3-10mm diameter vessels) showing Intima (Endothelial), Media (Smooth muscle) and 
Adventitia (Fibroblast). J) Fabrication of Biomimetic vessels. Fluorescently-labelled human endothelial 
(HUVEC-GFP), smooth muscle cells (SMC-mRFP) and fibroblasts (BJ6-GFP) were sequentially rolled to 
fabricate a tube mimicking muscular vessel architecture. The vessel was fabricated to create a sectioned 
structure to aid visualization. Bar is 2mm. 
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Figure 3. Real-time measurements of vessels. A) Photograph of perfusion bioreactor containing a tubular 
construct. The construct is held in position on culture jigs and is continually perfused using a peristaltic 
pump. Tube is shown with electrodes connected to an EVOM2 machine to allowing measurements of real-
time electrical resistance (TEER); Amplitude (I) and voltage (V) are measured within the lumen (V2 & I2) and 
externally to the tube within the perfusion chamber (I1 & V1). B) Photograph of construct secured in 
perfusion chamber with electrodes inserted within lumen. Bar is 10mm. C) Scanning electron microscope 
image of an acellular PET electrospun scaffold. Bar is 10µm. D) Immunostaining of E-Cadherin (red) in a 
confluent layer of CACO-2 cells on the PET electrospun scaffold before Ca2+ depletion, 5min, and 20min 
post-Ca2+ depletion (left to right). Bar is 60µm. E) Electrical resistance through CACO-2 tube after Ca2+ 
depletion. CACO-2-populated PET electrospun scaffold tube was fabricated and loaded into the perfusion 
bioreactor with electrodes placed as shown in (A). Ca2+ was depleted for 5min before replacement in 
normal media. Electrical resistance was measured periodically over a 24hr period. F) Para-cellular 
permeability through a CACO-2 tube. Acellular and CACO-2 populated electrospun tubes were placed in 
perfusion bioreactor. Serum-free media containing both 4kDa FITC-tagged and 70kDa Rhodamine-tagged 
dextran was perfused through the tube lumen. Samples from the perfusion chamber were taken over a 2hr 
period, and fluorescence expressed as a percentage of total initial fluorescence. G) Para-cellular 
permeability through a CACO-2 tube pre- and post-Ca2+ depletion. 
 
 
 
 
 
 
 
24 
 
Figure S1. 
 
 
 
 
 
 
 
 
 
Figure S1. Detachment of cell-only sheets and vessel fabrication. A) A mRFP-labelled NIH3t3 monolayer 
cell-only sheet detached from a PNIPAAm surface by lowering temperature. Sheets were transferred on 
filter paper frames (coated in cross-linked alginate). Bar is 12mm. B) Light and C) fluorescence microscopy 
of a detached mRFP-labelled NIH3t3 sheet. Bar is 100µm. A tube fabricated using the ATF from a cell-only 
sheet with 3 (Figure 1E) or D) 15 rotations. Bar is 3mm. ø is tube diameter. 
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Figure S2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2. Cell pattern transfer for tube fabrication. A flow diagram using photographic images of the 
process used to pattern cells on PNIPAAM-coated polystyrene and subsequently transfer patterns to 
alginate sheets. Bar is 20mm. 
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Figure S3. 
 
Figure S3. Excision of cell patterns for tube fabrication. A) A GFP-labelled NIH3t3 hydrogel sheet was 
excised to produce sheets of required cell orientations. B) An excised sheet with cell lines 60˚ from 
horizontal. C) A tube fabricated using the ATF from the sheet in B) showing helically orientated cells 
patterns. Bar is 0.5mm. 
 
 
